Glenmark's marketing portfolio as of December 2024 had 201 generic products authorised for distribution in the US. The ...

Global Bispecific Trispecific Antibodies Market Size Will Surpass US$ 50 Billion By 2030 Says Kuick ResearchDelhi, April 04, ...

a bispecific antibody. This indicates that trispecific antibodies may provide a more thorough approach to combating disease by activating additional pathways or immune responses. The capability to ...

EyeBio’s main asset is Restoret, an intravitreally delivered trispecific antibody that acts as an agonist of the Wnt signalling pathway and is in the phase 1b/2a AMARONE study in DME and ...

今日（3月26日），基石药业宣布，其5款自主研发创新药物的最新临床前研究成果将同时亮相2025年美国癌症研究协会（AACR）年会，包括 三抗 CS2009、 双抗 CS2011及 三款创新抗体偶联药物（ADC） CS5006、CS5007与CS5005。相关研究摘要将于美国东部时间4月11日发表于AACR官方期刊 Cancer Research。

Mission BioCapital (MBC), in partnership with sponsors Eli Lilly and Company (Lilly), Ono Venture Investment (OVI), Alloy Therapeutics, and our newest sponsor, HitGen, announced today that ...

J&J’s $2 billion play for Californian antibody-drug conjugate (ADC ... a pipeline of T-cell engagers based on trispecific proteins led by DLL3-targeting HPN328 for small cell lung cancer ...